PAL Lab at Temple University Leads Research on VitroGel® NEURON for Spinal Cord Injury

News banner with a spinal X-ray on the left and a headline about VitroGel NEURON for spinal cord repair, plus a bottle of VitroGel NEURON on the right.
Temple University Lewis Katz School of Medicine logo featuring the red Temple 'T' emblem and text below.

The PAL Lab at Temple University, led by Ajay Pal, Ph.D. has initiated a research study to evaluate VitroGel® NEURON, a fully synthetic hydrogel free of animal-derived components, as an injectable biomaterial for spinal cord injury repair.

Spinal cord injury remains a devastating condition with limited treatment options, often resulting in permanent neurological deficits and reduced quality of life. One of the major challenges following spinal cord injury is the hostile environment that develops at the lesion site. Cells struggle to survive, regenerative factors rapidly dissipate, and the damaged tissue provides minimal structural support for repair and regeneration.

Learn More

Biomaterial scaffolds have emerged as a promising strategy to address these challenges by creating a more supportive microenvironment and improving the retention of therapeutic agents at the injury site. Through this collaboration, researchers will investigate the potential of VitroGel® NEURON to support tissue repair and recovery following spinal cord injury.

The study will evaluate VitroGel® NEURON in a preclinical rat model of cervical spinal cord contusion, examining its effects on tissue response, functional recovery, and long-term outcomes. As a fully synthetic and animal-free hydrogel, VitroGel® NEURON offers a highly controlled and reproducible biomaterial platform designed to support advanced regenerative medicine applications.

“We are pleased to support the PAL Lab at Temple University in their research evaluating biomaterial-based approaches for spinal cord injury repair,” said TheWell Bioscience. “Advances in biomaterials continue to create new opportunities for regenerative medicine, and we look forward to contributing to this important research effort”.

TheWell Biosciences extends its sincere appreciation to the PAL Lab team for their partnership and commitment to advancing innovative therapeutic strategies for spinal cord injury. We look forward to sharing updates as the study progresses and new findings emerge.

Discover how our end-to-end platform can support your cell culture research

Explore our updated resources for a concise overview of VitroGel®’s key features and application areas.

Comparison of VitroGel® vs. Animal-based ECM

Discover the 20+ advantages of VitroGel® over animal-based ECM with this comprehensive comparison on key features, operation, application, and storage conditions.

Learn More

What is VitroGel®  | Overview Video

Learn why VitroGel® is the leading animal-free hydrogel for 3D cell culture.

Learn More